Key result
Type 2 diabetes impairs neurovascular coupling, a mechanism that may contribute to cognitive decline and can be evaluated using neuroimaging modalities such as MRI and PET.
Why the study?
Type 2 diabetes is an independent risk factor for cognitive decline, and early detection of detrimental changes in cerebral blood flow regulation may serve as a useful clinical marker for at-risk individuals.
Impaired neurovascular coupling represents a key pathophysiological link between type 2 diabetes and cognitive decline, offering a potential target for early detection and intervention.
May inform cognitive risk assessment in diabetes; hypothesis-generating for targeted trials.
Type 2 diabetes causes substantial long-term damage in several organs including the brain. Cognitive decline is receiving increased attention as diabetes has been established as an independent risk factor along with the identification of several other pathophysiological mechanisms. Early detection of detrimental changes in cerebral blood flow regulation may represent a useful clinical marker for development of cognitive decline for at-risk persons. Technically, reliable evaluation of neurovascular coupling is possible with several caveats but needs further development before it is clinically convenient. Different modalities including ultrasound, positron emission tomography and magnetic resonance are used preclinically to shed light on the many influences on vascular supply to the brain. In this narrative review, we focus on the complex link between type 2 diabetes, cognition, and neurovascular coupling and discuss how the disease-related pathology changes neurovascular coupling in the brain from the organ to the cellular level. Different modalities and their respective pitfalls are covered, and future directions suggested.
No takes yet. Share an insight, caveat, or question.
Barloese et al. (2022) conducted a review in Type 2 Diabetes with Cognitive Decline. Type 2 diabetes impairs neurovascular coupling, a mechanism that may contribute to cognitive decline and can be evaluated using neuroimaging modalities such as MRI and PET.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: